Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pro Medicus Limited ( (AU:PME) ) has issued an update.
Pro Medicus Limited’s U.S. subsidiary, Visage Imaging, Inc., has secured a 5-year contract renewal worth at least A$20 million with the Franciscan Missionaries of Our Lady Health System. The agreement includes the Visage 7 Viewer and a new Visage 7 Open Archive, both to be implemented in the cloud with a transaction-based model. This move highlights Pro Medicus’s strategic focus on transitioning clients to cloud-based solutions, potentially enhancing its market position and offering growth opportunities.
The most recent analyst rating on (AU:PME) stock is a Hold with a A$130.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited is a leading healthcare informatics company founded in 1983. It provides a comprehensive range of medical imaging software and services to hospitals, imaging centers, and healthcare groups globally. The company transformed into a global provider of advanced medical imaging solutions after acquiring Visage Imaging in 2009. Its Visage 7 suite offers a fast, clinically rich, and scalable platform for both public and private cloud environments, including RIS, PACS, AI, and e-health solutions.
Average Trading Volume: 236,346
Technical Sentiment Signal: Buy
Current Market Cap: A$29.43B
See more insights into PME stock on TipRanks’ Stock Analysis page.